Sumitomo Mitsui Trust Holdings Inc. lowered its stake in shares of Henry Schein Inc. (NASDAQ:HSIC) by 4.6% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 267,756 shares of the company’s stock after selling 12,811 shares during the period. Sumitomo Mitsui Trust Holdings Inc. owned approximately 0.33% of Henry Schein worth $47,339,000 at the end of the most recent reporting period.
Several other large investors also recently made changes to their positions in HSIC. Zurich Insurance Group Ltd FI acquired a new stake in shares of Henry Schein during the first quarter valued at about $3,204,000. National Pension Service increased its stake in shares of Henry Schein by 4.4% in the first quarter. National Pension Service now owns 56,059 shares of the company’s stock valued at $9,677,000 after buying an additional 2,383 shares in the last quarter. AMP Capital Investors Ltd increased its stake in shares of Henry Schein by 1.7% in the first quarter. AMP Capital Investors Ltd now owns 23,958 shares of the company’s stock valued at $4,141,000 after buying an additional 400 shares in the last quarter. Citizens Financial Group Inc RI increased its stake in shares of Henry Schein by 1.0% in the first quarter. Citizens Financial Group Inc RI now owns 46,377 shares of the company’s stock valued at $8,006,000 after buying an additional 452 shares in the last quarter. Finally, Prudential PLC increased its stake in shares of Henry Schein by 57.5% in the first quarter. Prudential PLC now owns 6,300 shares of the company’s stock valued at $1,088,000 after buying an additional 2,300 shares in the last quarter. 92.03% of the stock is owned by institutional investors and hedge funds.
Shares of Henry Schein Inc. (NASDAQ:HSIC) traded down 0.10% on Monday, hitting $153.21. The stock had a trading volume of 599,709 shares. The firm’s 50 day moving average is $162.17 and its 200-day moving average is $170.06. The stock has a market capitalization of $12.53 billion, a PE ratio of 25.95 and a beta of 1.05. Henry Schein Inc. has a one year low of $142.64 and a one year high of $183.00.
Henry Schein (NASDAQ:HSIC) last posted its earnings results on Thursday, August 4th. The company reported $1.64 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.63 by $0.01. The firm had revenue of $2.87 billion for the quarter, compared to analyst estimates of $2.85 billion. Henry Schein had a return on equity of 17.84% and a net margin of 4.42%. The company’s revenue for the quarter was up 9.3% on a year-over-year basis. During the same period in the previous year, the company posted $1.46 earnings per share. Equities research analysts expect that Henry Schein Inc. will post $6.57 earnings per share for the current fiscal year.
HSIC has been the subject of several research analyst reports. Zacks Investment Research downgraded Henry Schein from a “hold” rating to a “sell” rating in a research note on Monday, August 8th. Goldman Sachs Group Inc. raised Henry Schein from a “neutral” rating to a “buy” rating and set a $185.00 price objective for the company in a research note on Tuesday, October 11th. Robert W. Baird downgraded Henry Schein from an “outperform” rating to a “neutral” rating and reduced their price objective for the stock from $176.00 to $164.00 in a research note on Friday. Finally, Bank of America Corp. initiated coverage on Henry Schein in a research note on Monday, September 12th. They issued a “buy” rating and a $185.00 price objective for the company. One analyst has rated the stock with a sell rating, six have given a hold rating and five have assigned a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and a consensus target price of $159.50.
In other Henry Schein news, Director Paul Brons sold 3,381 shares of Henry Schein stock in a transaction dated Monday, August 29th. The stock was sold at an average price of $164.03, for a total transaction of $554,585.43. Following the transaction, the director now directly owns 13,715 shares in the company, valued at $2,249,671.45. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Company insiders own 1.27% of the company’s stock.
About Henry Schein
Henry Schein, Inc is a provider of health care products and services to office-based dental, animal health and medical practitioners. The Company’s segments include healthcare distribution, and technology and value-added services. The healthcare distribution segment aggregates its global dental, animal health and medical operating segments.